VTE Prophylaxis for High-Risk Ambulatory Cancer Patients? - Medscape

VTE Prophylaxis for High-Risk Ambulatory Cancer Patients?  Medscape

The use of direct oral anticoagulants for the prevention of venous thromboembolism (VTE) in high-risk ambulatory cancer patients showed promising results in ...



Comments

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review